Astrazeneca plc

NASDAQ: AZN
$66.58
-$1.47 (-2.2%)
Real Time Data Delayed 15 Min.

AZN Articles

Wednesday's additional top analyst upgrades and downgrades were on AstraZeneca, Bilibili, Electronic Arts, GoodRx, NetEase, Netflix, Pinterest, U.S. Foods and more.
Monday’s top analyst upgrades and downgrades included Affirm, AstraZeneca, Broadcom, Centene, Dell Technologies, Dollar General, Marvell Technology, Medical Properties Trust, Tesla, Ulta Beauty,...
Tuesday's additional top analyst upgrades and downgrades were on Adobe, AstraZeneca, Best Buy, Chemours, Oracle, Royalty Pharma, Teva Pharmaceutical and Tractor Supply.
Here are previews of three pharmaceutical giants set to report earnings before markets open on Friday.
Friday afternoon's top analyst upgrades and downgrades included Affirm, AstraZeneca, Block, CVS, Kellogg and more.
Tuesday afternoon's top analyst upgrades and downgrades included Alibaba, Apple, AstraZeneca, Canopy Growth, CNX Resources, Murphy Oil, Ross Stores and Tesla.
With the potential for far lower returns in the coming year, total return becomes a key ingredient for investment success. These five top health care stocks look like very solid ideas for 2022, as...
Here are previews of three earnings reports due for release before markets open on Friday.
24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Thursday, including American Express, Chipotle Mexican Grill, eBay, Nvidia, Qualcomm and Tesla.
Two pharmaceutical companies and a top media firm are on tap to report quarterly results before markets open on Thursday.
America's two largest energy companies report March quarter results Friday morning, along with two big pharmaceutical makers.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including AstraZeneca, Bumble, McDonald’s and Microsoft.
Tuesday's top analyst upgrades and downgrades included Adobe, Altria, AstraZeneca, Crowdstrike, Microsoft, Roblox, Starbucks, Ulta Beauty and Zoom Video Communications.
Thursday's top analyst upgrades and downgrades included AstraZeneca, Dollar General, Lowe’s, Nike, Nvidia, Shopify and Square.
Here’s a preview of four companies that will be reporting quarterly results before the markets open on Thursday.